Graduate Student
Entry into the Program: Fall 2025
Pronouns: He/Him
Advising Professor(s): Dr. Hyeun Ah Kang, Dr. Tyler J. Varisco
Education
- M.S. Pharmaceutical Outcomes and Policy Research, University of Pittsburgh School of Pharmacy, PA
- B.S. Pharmacy, China Medical University School of Pharmacy, Taiwan
Research Interests
- Clinical Outcomes, Economic Evaluation, Health Policy & Regulation, Pharmacoepidemiology
Presentations
- Suh K*, Cheng SH*, Lynch M, Shulman J, Korenoski A. Estimating the Cost Avoidance Associated with a Regional Poison Control Center. Am J Prev Med. 2026 Aug 20:108549. Doi: 10.1016/j.amepre.2026.108549 *Co-first authors
- Cheng SH, Novelli EM, Newman TV, Suh K, Kang H. Genotype Differences and Hydroxyurea Utilization Among Adults with Moderate to Severe Sickle Cell Disease. Pharmacotherapy. 2026;46(1). Doi:10.1002/phar.70099
Presentations
- Cheng, SH, Poorva B, Anton A. Cost-Effectiveness of Semaglutide and Liver Screening in MASLD Population. Poster presented at: ISPOR 2026; May 2026; Pennsylvania, The United States
- Cheng, S.H., Novelli, E.M., Newman, T.V., Suh, K. Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A Retrospective Cohort Study using Electronic Health Record Data. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025; May 2025; Montreal, Canada.
Contact Information
Why UTCOP HOD?
- UTCOP HOD has exceptional faculty members and scholars who create collaborative opportunities for research projects in the HEOR field, offering an ideal environment for contributing to meaningful health outcomes research that can impact patient care and healthcare policy.
What do you enjoy outside of school?
- I enjoy vintage shopping and cooking.